Sign in

NCT07242651Completed

Tension and Trauma Releasing Exercises on Hypertensive Patients

Effect of Tension and Trauma Releasing Exercises on Quality of Life and Sleep in Patients With Hypertension

Source: ClinicalTrials.gov · Last updated 28 Oct 2026

Brief summary (registry, in English)

The aim of this study is to investigate the effect of Tension and Trauma Releasing Exercises (TRE) on the quality of life and sleep in hypertensive patients. Participants will perform a series of supervised TRE sessions, and their sleep quality, and quality of life will be assessed before and after the intervention to determine any potential improvements related to the exercise.

Status (registry)
Completed
Study type
Interventional
Enrollment
40 (actual)
First submitted
17 Nov 2025
Start date
18 Nov 2025
Primary completion date
4 Mar 2026
Lead sponsor
Cairo University
NCT number
NCT07242651

What you commit to

  • Study type: Interventional
  • Participants enrolled: 40
  • From 18 Nov 2025 to the primary completion date, 4 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients suffering from any unstable cardiovascular condition, such as uncontrolled arrhythmias or recent myocardial infarction.
  • Patients are diagnosed with secondary hypertension.
  • Patients who are taking beta-blockers and alpha-blockers because these medications may affect heart rate.
  • Individuals with endocrine disorders or any condition known to influence hormonal levels.
  • Patients are smokers. h) Malignant hypertension.

Other

  • Patients with cognitive or physical impairments that prevent them from following instructions.

Who the study is looking for

  • Participants will be between 50 and 65 years of age.
  • The BMI of patients will range between 30 and 34.9.
  • Patients included in the study were diagnosed with essential hypertension for at least five years.
  • The patients will be in stage 1 hypertension under medical control, characterized by systolic blood pressure ranging from 140 to 159 mmHg and diastolic blood pressure ranging from 90 to 99 mmHg.

Age in the registry: 50 years to 65 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Faculty of Physical Therapy, Cairo University
Coordinator of this site? Confirm its status
GizaEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.